APA (7th ed.) Citation

AC, O., J, K., B, W., A, P., S, K., P, A., . . . K, U. (2024). Physiologically Based Pharmacokinetic Modeling to Predict the Impact of Liver Cirrhosis on Glucuronidation via UGT1A4 and UGT2B7/2B4-A Case Study with Midazolam. Drug metabolism and disposition: the biological fate of chemicals, 52(7), 614. https://doi.org/10.1124/dmd.123.001635

Chicago Style (17th ed.) Citation

AC, Ozbey, Keemink J, Wagner B, Pugliano A, Krähenbühl S, Annaert P, Fowler S, Parrott N, and Umehara K. "Physiologically Based Pharmacokinetic Modeling to Predict the Impact of Liver Cirrhosis on Glucuronidation via UGT1A4 and UGT2B7/2B4-A Case Study with Midazolam." Drug Metabolism and Disposition: The Biological Fate of Chemicals 52, no. 7 (2024): 614. https://doi.org/10.1124/dmd.123.001635.

MLA (9th ed.) Citation

AC, Ozbey, et al. "Physiologically Based Pharmacokinetic Modeling to Predict the Impact of Liver Cirrhosis on Glucuronidation via UGT1A4 and UGT2B7/2B4-A Case Study with Midazolam." Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 52, no. 7, 2024, p. 614, https://doi.org/10.1124/dmd.123.001635.